Bonn researchers reverse cell aging by up to 60 years without full stem-cell reset
A team led by Oliver Brüstle at Bonn University partially reprogrammed blood cells from donors ranging from an infant to a 101-year-old, stopping short of turning them into pluripotent stem cells. Within about two months, one key biomarker of cellular age was rolled back as much as 60 years, and the effect persisted even when the cells' ability to divide was sharply limited. The study, published in Aging Cell, also converted some blood cells into neuron-producing cells.
GoKawiil's interpretation of the reporting above, not reported fact.
Avoiding a fully pluripotent state matters because such cells risk forming tumors if introduced into the body, so this partial reprogramming approach could offer a safer route toward future anti-aging therapies. Brüstle says the next step is identifying the underlying mechanism before any attempt to apply the technique in living patients, since a lab result alone doesn't guarantee safe, systemic use. The finding that aging reversal continued despite reduced cell division suggests the rejuvenation isn't merely a side effect of generating new cells.
- Partial reprogramming rolled back a cellular aging biomarker by up to 60 years in two months.
- The method avoids the cancer risk tied to full pluripotent stem cell conversion.
- Researchers still need to identify the biological mechanism before considering use in patients.
Source: wired.com — Jorge Garay, 2026-11-11
Published there as: “A New Benchmark for De-Aging Comes From Slowly Turning Back Cells’ Clocks”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.